iBio to Participate in the Cantor 2021 Virtual Global Healthcare Conference
September 20 2021 - 4:30PM
iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of
next-generation biopharmaceuticals and pioneer of the sustainable,
plant-based
FastPharming Manufacturing System®,
today announced that the Company’s Chairman & CEO, Tom Isett,
and its CSO, Martin Brenner, DVM, Ph.D., will participate in a
fireside chat at the Cantor Virtual Global Healthcare Conference on
Monday, September 27, 2021 at 10:00 a.m. Eastern Time.
The fireside chat will be broadcast live and
archived on the Company's website at www.ibioinc.com under "News
& Events" in the Investors section.
About iBio, Inc.
iBio is a developer of next-generation
biopharmaceuticals and a pioneer in sustainable, plant-based
biologics manufacturing.
Its FastPharming System® combines
vertical farming, automated hydroponics, and novel glycosylation
technologies to rapidly deliver high-quality monoclonal antibodies,
vaccines, bioinks and other proteins. iBio is developing
proprietary biopharmaceuticals for the treatment of cancers, as
well as fibrotic and infectious diseases. The Company’s subsidiary,
iBio CDMO LLC,
provides FastPharming Contract
Development and Manufacturing Services along with
Glycaneering Development Services™ for
advanced recombinant protein design. For more information, visit
www.ibioinc.com.
Contact:
Stephen KilmeriBio, Inc.Investor Relations(646)
274-3580skilmer@ibioinc.com
iBio (AMEX:IBIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
iBio (AMEX:IBIO)
Historical Stock Chart
From Sep 2023 to Sep 2024